This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated KLF3 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-KLF3 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~38.8 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Ubl conjugation | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The PA1888 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Rat Testis, HELA (catalog PA1888) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | PA1888; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
KLF3 is predicted at 38.8 kDa; isoforms and phosphorylation could affect migration, but no empirical band or visible shift is established.
| Single band near 38.8 kDa | Consistent with the predicted KLF3 mass; confirm identity with controls |
| Two bands of uncertain spacing | Isoforms 1 and 2 could differ in migration; distinct bands are not established |
| Band with altered mobility | Phosphorylation could contribute; a visible shift is not established |
| Little signal in a cytoplasmic fraction | KLF3 is nuclear |
| Predicted KLF3 mass | 38.8 kDa is the sequence-based reference, not a measured band |
| Isoform 1 | May differ in migration from isoform 2; relative size is unknown |
| Isoform 2 | May differ in migration from isoform 1; relative size is unknown |
| Phosphoserines at residues 71, 92, 101, 108, 111, 216, 224, and 250 | Could affect mobility; no visible size change is demonstrated |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | Phosphorylation is possible, but its effect on migration is unproven | Compare phosphatase-treated and untreated samples with antibody specificity controls |
| Band lower than expected | Isoform-dependent migration is possible; isoform masses are unavailable | Check isoform expression and confirm band identity with an independent antibody |
| Multiple bands | Isoforms or phosphorylation states could contribute; distinct bands are unproven | Compare isoform controls and phosphatase-treated samples |
| Weak or no signal | Nuclear KLF3 may be poorly represented in the tested fraction | Check a nuclear fraction and its loading control |
| Fragments below expected size | Possible sample degradation; no KLF3 cleavage feature is supplied | Prepare fresh lysate with protease inhibitors and verify band identity |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Cerebellum | granular cells - nucleus | Medium | Protein (IHC) | HPA → |
| Endometrium | glandular cells | Medium | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Medium | Protein (IHC) | HPA → |
| Ovary | ovarian stroma cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for KLF3, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
PA1888 is the listed anti-KLF3 antibody, with reported reactivity to rat, mouse, and human. Its Western blot image shows rat testis tissue lysate and HeLa cell lysate; no mouse sample is shown in the supplied evidence.
Which to pick: PA1888 is the only listed option. Its Western blot image provides examples in rat testis tissue and HeLa cell lysates; choose it with your sample species and the limited shown contexts in mind.